R1	Has_negation Arg1:T3 Arg2:T2	
R2	Has_value Arg1:T4 Arg2:T5	
*	OR T6 T7 T8
*	OR T10 T11
R3	Subsumes Arg1:T11 Arg2:T12	
*	OR T12 T13
R4	AND Arg1:T6 Arg2:T10	
*	OR T17 T18 T19 T21
R5	Subsumes Arg1:T19 Arg2:T20	
R6	Subsumes Arg1:T16 Arg2:T17	
R7	Has_temporal Arg1:T23 Arg2:T24	
R8	Subsumes Arg1:T25 Arg2:T26	
R9	AND Arg1:T25 Arg2:T23	
R10	Has_qualifier Arg1:T27 Arg2:T28	
R11	AND Arg1:T29 Arg2:T30	
*	OR T29 T31 T32
R12	Subsumes Arg1:T27 Arg2:T29	
R13	Subsumes Arg1:T34 Arg2:T35	
R14	AND Arg1:T36 Arg2:T34	
*	OR T37 T38
*	OR T40 T41
R15	Subsumes Arg1:T39 Arg2:T40	
T1	Condition 13 35	primary sleep disorder
T2	Negation 36 41	other
T3	Condition 47 50	RLS
T4	Measurement 103 117	Serum ferritin
T5	Value 124 134	< 20 ng/mL
T6	Condition 161 168	allergy
T7	Condition 170 186	hypersensitivity
T8	Condition 191 202	intolerance
T10	Drug 206 214	HORIZANT
T11	Drug 228 238	gabapentin
T12	Drug 253 262	Neurontin
T13	Drug 265 272	Gralise
T16	Condition 294 311	movement disorder
T17	Condition 376 395	Tourette's syndrome
T18	Condition 397 409	tic disorder
T19	Condition 411 442	periodic limb movement disorder
T20	Condition 444 448	PLMD
T21	Condition 451 466	sleep disorders
T23	Condition 576 598	substance use disorder
T24	Temporal 620 636	within 12 months
T25	Measurement 485 554	Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition
T26	Measurement 556 561	DSM-5
T27	Condition 696 716	psychiatric disorder
T28	Qualifier 684 695	significant
T29	Condition 748 758	depression
T30	Drug 775 790	antidepressants
T31	Condition 793 809	bipolar disorder
T32	Condition 814 827	schizophrenia
T34	Condition 843 883	attention-deficit hyperactivity disorder
T35	Condition 885 889	ADHD
T36	Negation 894 901	allowed
T37	Observation 1006 1023	suicidal behavior
T38	Condition 1027 1044	suicidal ideation
T39	Condition 1194 1210	seizure disorder
T40	Condition 1301 1328	complicated febrile seizure
T41	Condition 1356 1367	head injury
T43	Non-query-able 1370 1758	Medical condition or disorder that would interfere with the action, absorption, distribution, metabolism, or excretion of gabapentin enacarbil, or, in the investigator's judgment is considered to be clinically significant and may pose a safety concern, or, could interfere with the accurate assessment of safety or efficacy, or could potentially affect a patient's safety or study outcome
T44	Non-query-able 1761 1891	Clinically significant abnormal laboratory result or physical examination finding not resolved by the time of baseline assessments
